Thermo Fisher Scientific is trading 4.5% down at $542.78 in pre-market as investors lock in profits following last week's strong earnings-driven gains.
- Shares previously surged after the company beat Q2 expectations and raised its full-year guidance.
- There is no fresh, company-specific negative news tied to this morning's move, suggesting a technical pullback after the recent rally.
- The decline occurs even as broader market indices trade higher during the pre-market session.